AIM: To evaluate the clinical efficacy of topical 0. 05% cyclosporine nano-emulsion in the treatment of dry eye syndrome (DES) with meibomian gland dysfunction (MGD). METHODS: This prospective study included 64 patients with DES and MGD who were randomly assigned to three groups: Group 1 (n=24. conventional cyclosporine). https://www.roneverhart.com/Tallarn-Sand/